Evidence map›Paper›PMID 39445343›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes.

Luciana Mascarenhas Fonseca, Michal Schnaider Beeri, Zoë W Hawks, Lanee Jung, Michael Cleveland, Nikki Delgado, Jane Bulger, Elizabeth Grinspoon, Kamille Janess, Martin J Sliwinski and 5 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Luciana Mascarenhas FonsecaElson S. Floyd College of Medicine Washington State University Spokane Washington USA.
Michal Schnaider BeeriHerbert and Jacqueline Krieger Klein Alzheimer's Research Center Rutgers University New Brunswick New Jersey USA.
Zoë W HawksInstitute for Technology in Psychiatry McLean Hospital Belmont Massachusetts USA.
Lanee JungInstitute for Technology in Psychiatry McLean Hospital Belmont Massachusetts USA.
Michael ClevelandDepartment of Human Development Washington State University Pullman Washington USA.
Nikki DelgadoElson S. Floyd College of Medicine Washington State University Spokane Washington USA.
Jane BulgerDepartment of Medicine SUNY Upstate Medical University Syracuse New York USA.
Elizabeth GrinspoonInstitute for Technology in Psychiatry McLean Hospital Belmont Massachusetts USA.
Kamille JanessResearch Center and a Hospital Jaeb Center for Health Research Tampa Florida USA.
Martin J SliwinskiDepartment of Human Development and Family Studies Pennsylvania State University University Park State College Pennsylvania USA.
Ruth S WeinstockDepartment of Medicine SUNY Upstate Medical University Syracuse New York USA.
Jasmeer P ChhatwalDepartment of Neurology Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA.
Pia KivisäkkDepartment of Neurology Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA.
Laura Thi GermineInstitute for Technology in Psychiatry McLean Hospital Belmont Massachusetts USA.
Naomi S ChaytorElson S. Floyd College of Medicine Washington State University Spokane Washington USA.

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Sudeshna Das · 2019 to 2026
$36.5M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Amanda D. Boyd · 2020 to 2026
$29.0M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Glycemic Variability and Fluctuations in Cognitive Status in Adults with Type 1 DiabetesR01DK121240 · NIDDK · MCLEAN HOSPITAL · PI CHAYTOR, NAOMI SAGE, GERMINE, LAURA THI · 2019 to 2022
$3.1M
Intraindividual cognitive variability in aging adults with Down syndrome: associations with Alzheimer's disease plasma biomarkers, neuropathology and clinical dementiaK99AG082864 · NIA · WASHINGTON STATE UNIVERSITY · PI FONSECA, LUCIANA · 2023 to 2024
$256k
NIA NIH HHS K99 AG082864NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG066509NIDDK NIH HHS P30 DK111022NIDDK NIH HHS R01 DK121240
6 · The paper itself

Abstract

introductionAssociations between amyloid-tau-neurodegeneration (ATN) plasma biomarkers and cognition have not been characterized in adults with type 1 diabetes (T1D).

methodsUsing data from participants in the Glycemic Variability and Fluctuations in Cognitive Status in Adults with T1D (GluCog) study (

resultsHigher concentrations of pTau181 and GFAP were associated with slower responses on working memory tasks (pTau181: Discussion: Digital cognitive performance was associated with several ATN plasma biomarkers in T1D adults. Prospective studies are needed to understand the utility of these biomarkers in T1D. Highlights: There is an increase in life expectancy for individuals with type 1 diabetes (T1D).Few studies investigate the relationship between T1D and neurodegeneration.We characterize the relation between ATN plasma biomarkers and cognitive function.Digital cognitive performance was associated with plasma biomarkers in T1D adults.

Indexed as

Alzheimer's diseasecognitionplasma biomarkerstype 1 diabetes

Identifiers

PMID39445343
PMCPMC11497176

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.